Latest Breaking News On - Mark mcpartland - Page 4 : comparemela.com

Vistagen Receives Notice of Allowance for AV-101 Canadian Patent for Treatment of Dyskinesia Related

Oral levodopa is the gold standard treatment for motor symptoms in individuals diagnosed with Parkinson’s disease, despite the risk of dyskinesia (sudden uncontrolled movements) related to long-term use of levodopaPublished preclinical data in widely used MPTP non-human primate model of Parkinson's disease show AV-1.

United statesNate hitchingsMark mcpartlandExchange commissionCanadian intellectual property officeTrademark officeLaval research centerFaculty of pharmacy at laval universityEmeritus professorLaval universityAnnual reportVice presidentInvestor relations

VistaGen Therapeutics (VTGN) Receives Notice of Allowance for AV-101 Canadian Patent

VistaGen Therapeutics (VTGN) Receives Notice of Allowance for AV-101 Canadian Patent
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMark mcpartlandNate hitchingsFaculty of pharmacy at laval universityLaval research centerTrademark officeExchange commissionCanadian intellectual property officeEmeritus professorLaval universityAnnual reportVice president

VistaGen Therapeutics (VTGN) Reports Positive Results from Exploratory Phase 2A Study of PH80 in Women Diagnosed with Menopausal Hot Flashes

VistaGen Therapeutics (VTGN) Reports Positive Results from Exploratory Phase 2A Study of PH80 in Women Diagnosed with Menopausal Hot Flashes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMark mcpartlandNate hitchingsExchange commissionAnnual reportQuarterly reportVice president

Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 in Women Diagnosed with

PH80 nasal spray demonstrates statistically significant efficacy versus placebo in exploratory double-blind, placebo-controlled Phase 2A study (n=36) in women diagnosed with menopausal hot flashesPH80 was safe and well-tolerated with an adverse event profile similar to placeboSOUTH SAN FRANCISCO, Calif. (BUSINESS W.

United statesNate hitchingsMark mcpartlandExchange commissionAnnual reportQuarterly reportVice presidentInvestor relations

VistaGen Therapeutics (VTGN) Announces Stockholder-Approved 1:30 Reverse Stock Split

VistaGen Therapeutics (VTGN) Announces Stockholder-Approved 1:30 Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mark mcpartlandNate hitchingsExchange commission onComputershare trust companyCompany board of directorsExchange commissionWall streetNasdaq capital marketListing rulesNasdaq stock marketAnnual reportQuarterly reportVice president